Published in Circ Res on August 01, 1997
Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 4.96
Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A (1998) 2.60
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res (2008) 2.22
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J (2001) 2.19
Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol (2000) 2.10
Conditional lineage ablation to model human diseases. Proc Natl Acad Sci U S A (1998) 1.64
Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest (1999) 1.58
Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol (2007) 1.55
Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury. J Mol Cell Cardiol (2008) 1.44
Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest (2002) 1.43
Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem (2011) 1.27
RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. PLoS One (2010) 1.15
Morphological aspects of apoptosis in heart diseases. J Cell Mol Med (2006) 1.09
The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions? Cell Stress Chaperones (2009) 1.08
Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci U S A (2002) 1.02
Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway. Am J Physiol Heart Circ Physiol (2011) 0.97
Development of left ventricular diastolic dysfunction with preservation of ejection fraction during progression of infant right ventricular hypertrophy. Circ Heart Fail (2009) 0.95
Chronic right ventricular pressure overload results in a hyperplastic rather than a hypertrophic myocardial response. J Anat (2008) 0.93
Sex differences in myocardial metabolism and cardiac function: an emerging concept. Pflugers Arch (2013) 0.92
Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction. Am J Physiol Cell Physiol (2009) 0.92
Cell death, tissue hypoxia and the progression of heart failure. Heart Fail Rev (2000) 0.91
Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway. Exp Mol Med (2011) 0.91
Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice. J Physiol (2011) 0.91
Autophagy in the myocardium: Dying for survival? Exp Clin Cardiol (2006) 0.89
The role of curcumin on intestinal oxidative stress, cell proliferation and apoptosis after ischemia/reperfusion injury in rats. J Mol Histol (2011) 0.88
Gone fission…: diverse consequences of cardiac Drp1 deficiency. Circ Res (2015) 0.88
Safflor yellow A protects neonatal rat cardiomyocytes against anoxia/reoxygenation injury in vitro. Acta Pharmacol Sin (2013) 0.85
Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury. BMC Complement Altern Med (2006) 0.85
Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure. BMC Physiol (2003) 0.83
Dental pulp-derived stem cell conditioned medium reduces cardiac injury following ischemia-reperfusion. Sci Rep (2015) 0.82
Methanolic extract of onion (Allium cepa) attenuates ischemia/hypoxia-induced apoptosis in cardiomyocytes via antioxidant effect. Eur J Nutr (2009) 0.81
Effects of hypothalamic paraventricular nuclei on apoptosis and proliferation of gastric mucosal cells induced by ischemia/reperfusion in rats. World J Gastroenterol (2007) 0.80
Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol (1998) 0.78
Protective effect of ginsenoside Rg1 on lidocaine-induced apoptosis. Mol Med Rep (2013) 0.78
Prevention of deleterious effects of reperfusion injury using one-week high-dose allopurinol. Dig Dis Sci (2001) 0.78
Blockage of transient receptor potential vanilloid 4 alleviates myocardial ischemia/reperfusion injury in mice. Sci Rep (2017) 0.75
Cardioprotective effect of ammonium glycyrrhizinate against doxorubicin-induced cardiomyopathy in experimental animals. Indian J Pharmacol (2014) 0.75
Total saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway. Int J Mol Med (2015) 0.75
Beta blockers in heart failure haemodynamics, clinical effects and modes of action. Neth Heart J (2001) 0.75
Computational modeling of acute myocardial infarction. Comput Methods Biomech Biomed Engin (2015) 0.75
MAPK1 up-regulates the expression of MALAT1 to promote the proliferation of cardiomyocytes through PI3K/AKT signaling pathway. Int J Clin Exp Pathol (2015) 0.75
Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest (1997) 5.19
Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res (2001) 4.38
Genetic dissection of cardiac growth control pathways. Annu Rev Physiol (2000) 2.41
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature (1998) 2.31
TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med (2000) 2.29
Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest (1990) 2.25
Inducible gene targeting in postnatal myocardium by cardiac-specific expression of a hormone-activated Cre fusion protein. Circ Res (2001) 1.93
Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A (2001) 1.83
A topographic gradient of molecules in retina can be used to identify neuron position. Proc Natl Acad Sci U S A (1981) 1.77
A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J Biol Chem (1993) 1.63
Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest (1997) 1.62
Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation. Mol Cell Biol (1987) 1.52
Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest (1993) 1.51
Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol (2005) 1.48
Transforming growth factor-beta response elements of the skeletal alpha-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J Biol Chem (1994) 1.46
p21 Ras as a governor of global gene expression. J Biol Chem (1994) 1.43
A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol (2000) 1.40
Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Annu Rev Physiol (1991) 1.25
Mitogens and oncogenes can block the induction of specific voltage-gated ion channels. Science (1987) 1.24
The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load. J Clin Invest (1991) 1.24
Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem (1995) 1.23
A hemodynamic load in vivo induces cardiac expression of the cellular oncogene, c-myc. Biochem Biophys Res Commun (1987) 1.18
An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Proc Natl Acad Sci U S A (1987) 1.17
Transforming growth factor-beta in cardiac ontogeny and adaptation. Circ Res (1993) 1.16
Serum response factor mediates AP-1-dependent induction of the skeletal alpha-actin promoter in ventricular myocytes. J Biol Chem (1996) 1.16
Requirement for TGFbeta receptor signaling during terminal lens fiber differentiation. Development (2001) 1.11
Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev Biol (1996) 1.11
Quantitative assay of Coxiella burnetii in mice. Appl Microbiol (1966) 1.10
The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function. J Mol Cell Cardiol (1995) 1.09
FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors. J Biol Chem (1996) 1.06
Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors. Proc Natl Acad Sci U S A (1990) 1.05
Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease. Proc Natl Acad Sci U S A (1981) 1.05
Ca2+ and Na+ currents in developing skeletal myoblasts are expressed in a sequential program: reversible suppression by transforming growth factor beta-1, an inhibitor of the myogenic pathway. J Neurosci (1989) 1.04
A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy. Mol Cell Biol (1998) 1.00
A constitutive mutation of ALK5 disrupts cardiac looping and morphogenesis in mice. Dev Biol (1998) 0.97
A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor. J Biol Chem (1998) 0.96
Survival time and retention of antimalarial resistance of malarial parasites in repository in liquid nitrogen (--196 C). Appl Microbiol (1968) 0.96
Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response. J Cell Biol (1988) 0.95
Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription. J Biol Chem (1995) 0.95
Adsorption of Wild Rabies Virus and Neurotropic-Adapted Viruses by Activated Attapulgite. Can J Comp Med Vet Sci (1964) 0.94
Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B. J Viral Hepat (2012) 0.93
Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone. J Biol Chem (2001) 0.92
Dissociated expression of c-myc and a fos-related competence gene during cardiac myogenesis. Mol Cell Biol (1986) 0.92
E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2. Circ Res (1999) 0.92
Transfer plate radioassay using cell monolayers to detect anti-cell surface antibodies synthesized by lymphocyte hybridomas. J Immunol Methods (1979) 0.88
Extended low-temperature storage of a highly lethal Plasmodium berghei strain. Am J Vet Res (1970) 0.86
Influence of various cooling and warming temperatures on survival after thawing of cryopreserved Plasmodium berghei. Cryobiology (1973) 0.86
The syndromes of familial atrioventricular block with sinus bradycardia: prognostic indices, electrophysiologic and histopathologic correlates. Eur J Cardiol (1978) 0.85
Control of expression of the 1,4-dihydropyridine receptor in BC3H1 cells. Biochem Biophys Res Commun (1988) 0.84
AT(2), judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy? Circulation (2001) 0.82
An effector-like function of Ras GTPase-activating protein predominates in cardiac muscle cells. J Biol Chem (1997) 0.81
Transforming growth factor-beta signal transduction. Circ Res (1996) 0.81
Some clinical and microbiological findings in vervet monkeys (Cercopithecus aethiops pygerythrus). Lab Anim Sci (1971) 0.81
Chips ahoy: gene expression in failing hearts surveyed by high-density microarrays. Circulation (2000) 0.81
Success in failure: modeling cardiac decompensation in transgenic mice. Circulation (1998) 0.81
Life span and tissue distribution of 111indium-labeled blood platelets in hypomagnesemic lambs. Am J Vet Res (1983) 0.80
Dihydropyridine receptor gene expression is regulated by inhibitors of myogenesis and is relatively insensitive to denervation. J Clin Invest (1990) 0.80
Localization and topography of antigenic domains within the heavy chain of smooth muscle myosin. J Cell Biol (1985) 0.79
The cardiac cell cycle, pocket proteins, and p300. Trends Cardiovasc Med (2011) 0.79
Cellular oncogenes in cardiovascular disease. J Mol Cell Cardiol (1988) 0.78
Purification of a membrane protein distributed in a topographic gradient in chicken retina. Proc Natl Acad Sci U S A (1986) 0.77
TGF-beta 1 and fibroblast growth factors selectively up-regulate tissue-specific fetal genes in cardiac muscle cells. Ciba Found Symp (1991) 0.77
Characteristics and cross-resistance patterns of chloroquine-resistant Plasmodium berghei infections in mice. Exp Parasitol (1968) 0.76
Functional aspects of blood platelets in irradiated burros. Am J Vet Res (1977) 0.76
Surviving infarction one gene at a time: decreased remodeling and mortality in engineered mice lacking the angiotensin II type 1A receptor. Circulation (1999) 0.75
Missing pieces: myosin binding protein C truncations in familial hypertrophic cardiomyopathy. Circ Res (1997) 0.75
Cyclin-dependent kinase-2 in the birth and death of cardiac muscle cells. Circ Res (2001) 0.75
Immunofluorescence study of wild rabies virus and antibody. Can J Comp Med Vet Sci (1966) 0.75
Safety of intraaortic balloon pumping. II. Physical injury to aortic endothelium due to mechanical pump action. Thromb Res (1974) 0.75
Burro aortic collagen: composition and characteristics of interaction with platelets. Am J Vet Res (1979) 0.75
Hematologic, biochemical, and pathologic effects of intra-aortic balloon counterpulsation in the calf. Surg Gynecol Obstet (1973) 0.75
Nature of thrombus in a hollow fiber oxygenator. Am J Vet Res (1973) 0.75
Platelet affinity for burro aorta collagen. Am J Vet Res (1977) 0.75
Images in cardiovascular medicine. Detection of exogenous gene expression in live adult ventricular myocytes after adenoviral gene delivery. Circulation (1994) 0.75
Awards and named lectures at the 68th scientific sessions. Circulation (1996) 0.75
A proposed mechanism(s) of transitory ischemic injury to myocardium. Am J Vet Res (1979) 0.75
Effect of transforming growth factor-beta 1 on myocardial stunning in the intact dog. J Mol Cell Cardiol (1993) 0.75
Plasma clot-promoting effect of collagen in relation to collagen-platelet interaction. Am J Vet Res (1981) 0.75
Effects of hypomagnesemia on reactivity of bovine and ovine platelets: possible relevance to infantile apnea and sudden infant death syndrome. J Am Coll Nutr (1990) 0.75
Role of the blood platelet in the pathogenesis and complications of experimental myocardial ischemia. Am J Vet Res (1980) 0.75
Molecules that define a dorsal-ventral axis of retina can be used to identify cell position. Adv Exp Med Biol (1982) 0.75
Burro aortic collagen: platelet aggregating activity and ultrastructural changes induced by plasma. Am J Vet Res (1978) 0.75
Safety of intraaortic balloon pumping. I. Biochemic and hematologic values influenced by use of balloon. Thromb Res (1974) 0.75
Particulate emboli retained by bypass blood filters. Scand J Haematol (1974) 0.75